Oncostatin M Reduces Lesion Size and Promotes Functional Recovery and Neurite Outgrowth After Spinal Cord Injury

Advances in the Management of Spinal Cord Injury

(2016) Ranjan Gupta et al.   JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS

Involvement of IL-1 and Oncostatin M in Acanthosis Associated With Hypertensive Leg Ulcer

(2013) Jean-Philippe Giot et al.   AMERICAN JOURNAL OF PATHOLOGY

The SCIentinel study - prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS) - study protocol and interim feasibility data

(2013) Marcel A Kopp et al.   BMC Neurology

Lack of Oncostatin M Receptor β Leads to Adipose Tissue Inflammation and Insulin Resistance by Switching Macrophage Phenotype

(2013) Tadasuke Komori et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pulmonary Expression of Oncostatin M (OSM) Promotes Inducible BALT Formation Independently of IL-6, Despite a Role for IL-6 in OSM-Driven Pulmonary Inflammation

(2013) F. M. Botelho et al.   JOURNAL OF IMMUNOLOGY

Absence of IL-1β positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury

(2013) Francesco Boato et al.   Journal of Neuroinflammation

ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice

(2013) P M Vidal et al.   Cell Death & Disease

The role of “anti-inflammatory” cytokines in axon regeneration

(2012) Pía M. Vidal et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Evaluating the role of IL-11, a novel cytokine in the IL-6 family, in a mouse model of spinal cord injury

(2012) Newton Cho et al.   Journal of Neuroinflammation

Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice

(2012) Alexander Rodriguez Guerrero et al.   Journal of Neuroinflammation

LIF in the regulation of T-cell fate and as a potential therapeutic

(2011) S M Metcalfe   GENES AND IMMUNITY

Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro

(2011) Francesco Boato et al.   Journal of Neuroinflammation

Oncostatin M Protects Rod and Cone Photoreceptors and Promotes Regeneration of Cone Outer Segment in a Rat Model of Retinal Degeneration

(2011) Xin Xia et al.   PLoS One

Regulatory T cells in CNS injury: the simple, the complex and the confused

(2011) James T. Walsh et al.   TRENDS IN MOLECULAR MEDICINE

Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment

(2010) Kevin D. Beck et al.   BRAIN

Oncostatin M is a novel glucocorticoid-dependent neuroinflammatory factor that enhances oligodendrocyte precursor cell activity in demyelinated sites

(2010) Isaias Glezer et al.   BRAIN BEHAVIOR AND IMMUNITY

Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation

(2010) Masahiko Mukaino et al.   EXPERIMENTAL NEUROLOGY

IL-27 inhibits OSM-mediated TNF-α and iNOS gene expression in microglia

(2010) Brandi J. Baker et al.   GLIA

C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts

(2010) F. Boato et al.   JOURNAL OF CELL SCIENCE

Interleukin-6-type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function

(2010) Shamsudheen Moidunny et al.   JOURNAL OF NEUROCHEMISTRY

Therapeutic potential of LIF in multiple sclerosis

(2010) Helena Slaets et al.   TRENDS IN MOLECULAR MEDICINE

Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3

(2008) Helena Slaets et al.   PROTEOMICS

Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury

(2007) Dustin J. Donnelly et al.   EXPERIMENTAL NEUROLOGY